
Rua Bioscience closes its oversubscribed $20m offer
Medicinal cannabis firm Rua Bioscience closed its initial public offering on Friday having raised $20 million after both its priority and broker offers were "well oversubscribed", meaning applications will be scaled for retail investors and a "small number" of New Zealand institu...

Truscreen tech success in Chinese cancer trials
Truscreen Group has announced its cervical cancer screening technology has produced encouraging results in the second phase of preliminary trials in Sichuan Province, China.Truscreen’s medical device picks up electrical and optical signals to deliver fast results that don't r...


Air NZ to operate first quarantine free flight to Australia
Air New Zealand will operate its first flight as part of the Safe Travel Zone with New South Wales tomorrow.The Safe Travel Zone is a one-way arrangement. People returning to New Zealand will still need to quarantine for 14 days upon return, provide payment for quarantine and reg...